Ann Dermatol.  2017 Aug;29(4):523-524. 10.5021/ad.2017.29.4.523.

A Case of Bowen's Disease Successfully Treated with Ingenol Mebutate Gel

• Chae JB
• Park JT
• Kim BR
• Huh CH
• Park KC
• Shin JW

• KMID: 2388964
• DOI: http://doi.org/10.5021/ad.2017.29.4.523

Abstract

No abstract available.

MeSH Terms

Bowen's Disease*

Figure

• 

  Fig. 1 (A) Bowen's disease lesion on the leg of the first case. (B) 2 years after application of 0.05% ingenol mebutate gel on the lesion combined with fractional carbondioxide laser. (C) Histopathologic image before treatment. There is full-thickness intraepidermal cellular atypia along with nuclear hyperchromasia and dyskeratotic cells (D) Follow-up skin biopsy revealed no evidance of recurrance observed. Only mild irregular acanthosis with dermal fibrosis presented (H&E; C, D: ×200).

Reference

1. Lebwohl M, Swanson N, Anderson LL, Melgaard A, Xu Z, Berman B. Ingenol mebutate gel for actinic keratosis. N Engl J Med. 2012; 366:1010–1019.

2. Rosen RH, Gupta AK, Tyring SK. Dual mechanism of action of ingenol mebutate gel for topical treatment of actinic keratoses: rapid lesion necrosis followed by lesion-specific immune response. J Am Acad Dermatol. 2012; 66:486–493.

3. Salleras Redonnet M, Quintana Codina M. Ingenol mebutate gel for the treatment of Bowen's disease: a case report of three patients. Dermatol Ther. 2016; 29:236–239.

4. Lee JH, Lee JH, Bae JM, Kim GM. Successful treatment of Bowen's disease with ingenol mebutate 0.05% gel. J Dermatol. 2015; 42:920–921.

5. Jang YH, Lee DJ, Shin J, Kang HY, Lee ES, Kim YC. Photodynamic therapy with ablative carbon dioxide fractional laser in treatment of actinic keratosis. Ann Dermatol. 2013; 25:417–422.